Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Inventory (2020 - 2025)

Biofrontera has reported Inventory over the past 6 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Inventory at $1.4 million for Q4 2025, down 78.54% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (down 78.54% YoY), and the annual figure for FY2025 was $1.4 million, down 78.54%.
  • Inventory for Q4 2025 was $1.4 million at Biofrontera, down from $4.3 million in the prior quarter.
  • Over the last five years, Inventory for BFRIW hit a ceiling of $16.1 million in Q3 2023 and a floor of $1.4 million in Q4 2025.
  • Median Inventory over the past 5 years was $6.5 million (2025), compared with a mean of $6.9 million.
  • Biggest five-year swings in Inventory: surged 122.23% in 2022 and later crashed 78.54% in 2025.
  • Biofrontera's Inventory stood at $4.5 million in 2021, then surged by 60.79% to $7.2 million in 2022, then skyrocketed by 52.18% to $10.9 million in 2023, then tumbled by 39.07% to $6.6 million in 2024, then crashed by 78.54% to $1.4 million in 2025.
  • The last three reported values for Inventory were $1.4 million (Q4 2025), $4.3 million (Q3 2025), and $4.0 million (Q2 2025) per Business Quant data.